ARTICLE | Company News
Aeterna Zentaris, China National Pharmaceutical Group deal
December 22, 2014 8:00 AM UTC
Sinopharm’s Sinopharm A-Think subsidiary received exclusive rights from Aeterna Zentaris to develop and commercialize Zoptarelin doxorubicin acetate to treat endometrial cancer in China, including Hon...